Contribution of glimepiride to basal–prandial insulin therapy in patients with type 2 diabetes.
- diciembre 19, 2018
- Sin comentarios aún.
Aim: To investigate the efficacy of continuing glimepiride in combination with basal–prandial insulin therapy in type 2 diabetes. Methods: An open crossover study was performed with arms of discontinuation and continuation of glimepiride in 25 subjects with mean diabetes duration of 17 years and 5 years of insulin treatment combined...